Robert Goldberg is co-founder and vice president of the Center for Medicine in the Public Interest.  Along with Peter Pitts, Dr. Goldberg hosts the popular and controversial blog on the pharmaceutical industry and health care,

Prior to founding CMPI, Goldberg was Director of the Manhattan Institute’s Center for Medical Progress and Chairman of it’s 21st Century FDA Task Force which examined the impact of the FDA’s Critical Path Initiative on drug development and personalized medicine.

He is the author of numerous articles and reports including “Stealing U.S. drug patents,” “The Right Road to Safe Drugs,” “Don’t blame Canada,” and “Medicare’s Future.” In February 2005, Goldberg testified before the Senate Committee on Heath, Education, Labor and Pensions on drug importation. He has written for The Wall Street Journal, The Washington Post, the Los Angeles Times, National Review Online, The Weekly Standard, The Chicago Tribune, The Philadelphia Inquirer, The New York Post, The New York Sun and writes regularly for The Washington Times.

He is an expert on Medicare reform, reimportation of medicines from Canada and the role genomics, bioinformatics and nanotechnology will have in transforming the health care system and health care in general. He has conducted and supported original research on the impact restrictive drug formularies have had on health outcomes on seniors and critical ill patients.  His current research will focus on evaluating the value of personalized, preventative medical technologies to society and to health systems.